{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:42Z","timestamp":1793726022993,"version":"4.6.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271309"],"award-info":[{"award-number":["82271309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071314"],"award-info":[{"award-number":["82071314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.phrs.2025.107658","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:12:38Z","timestamp":1739934758000},"page":"107658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Interleukin-2 and its receptors: Implications and therapeutic prospects in immune-mediated disorders of central nervous system"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6549-8600","authenticated-orcid":false,"given":"Yiwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-1527","authenticated-orcid":false,"given":"Haiping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107658_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-199801000-00001","article-title":"Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration","volume":"57","author":"Neumann","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.phrs.2025.107658_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2025.107658_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163-164","author":"Jiang","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107658_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11481-018-9821-6","article-title":"Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis","volume":"14","author":"Liu","year":"2019","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.phrs.2025.107658_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0165-0173(95)00015-1","article-title":"Interleukin-2 as a neuroregulatory cytokine","volume":"21","author":"Hanisch","year":"1995","journal-title":"Brain Res Rev."},{"key":"10.1016\/j.phrs.2025.107658_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-62703-071-7_15","article-title":"Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models","volume":"934","author":"Petitto","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107658_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.1990.tb40478.x","article-title":"Interleukin-2 effects in the central nervous system","volume":"594","author":"Merrill","year":"1990","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","article-title":"Treatment options in refractory autoimmune encephalitis","volume":"36","author":"Dinoto","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2025.107658_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70102-1","article-title":"Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells","volume":"10","author":"Kupz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107658_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","article-title":"PD-1 combination therapy with IL-2 modifies CD8+\u2009T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107658_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/imm.13719","article-title":"New sights of low dose IL-2: Restoration of immune homeostasis for viral infection","volume":"171","author":"Su","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2025.107658_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/NMM:7:3:183","article-title":"T-cell cytokines in injury-induced neural damage and repair","volume":"7","author":"Schroeter","year":"2005","journal-title":"Neuromolecul. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Gra\u00dfhoff","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib16","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00415-023-11690-6","article-title":"A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis","volume":"270","author":"Louapre","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-2427(94)90015-9","article-title":"Cross-species PCR cloning of gerbil (Meriones unguiculatus) interleukin-2 cDNA and its expression in COS-7 cells","volume":"40","author":"Mai","year":"1994","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.phrs.2025.107658_bib18","first-page":"286","article-title":"Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4","volume":"75","author":"McKnight","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2025.107658_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: biology, design and application","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni0901-882","article-title":"Inducible IL-2 production by dendritic cells revealed by global gene expression analysis","volume":"2","author":"Granucci","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib22","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.4049\/jimmunol.172.8.4691","article-title":"Preferential activation of an IL-2 regulatory sequence transgene in TCR gamma delta and NKT cells: subset-specific differences in IL-2 regulation","volume":"172","author":"Yui","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/eji.200425899","article-title":"Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+\u2009regulatory T cells?","volume":"35","author":"Jiang","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1479-5876-7-89","article-title":"Human T cells express CD25 and Foxp3 upon activation and exhibit effector\/memory phenotypes without any regulatory\/suppressor function","volume":"7","author":"Kmieciak","year":"2009","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.iy.11.040193.001333","article-title":"The IL-2 receptor complex: its structure, function, and target genes","volume":"11","author":"Minami","year":"1993","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191247","article-title":"Effects of interleukin-2 in immunostimulation and immunosuppression","volume":"217","author":"Pol","year":"2020","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.1631559","article-title":"Cloning of the gamma chain of the human IL-2 receptor","volume":"257","author":"Takeshita","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107658_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjh.14770","article-title":"The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer","volume":"179","author":"Flynn","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.phrs.2025.107658_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/00313029109063570","article-title":"Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro","volume":"23","author":"Lai","year":"1991","journal-title":"Pathology"},{"key":"10.1016\/j.phrs.2025.107658_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-3083.2009.02268.x","article-title":"CD25 shedding by human natural occurring CD4+CD25+\u2009regulatory T cells does not inhibit the action of IL-2","volume":"70","author":"Pedersen","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib31","first-page":"220","article-title":"Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases","volume":"78","author":"Dik","year":"2020","journal-title":"Neth. J. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.938556","article-title":"Increased sIL-2R\u03b1 leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients via binding to IL-2","volume":"13","author":"Long","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/imm.13723","article-title":"The soluble IL-2 receptor \u03b1\/CD25 as a modulator of IL-2 function","volume":"171","author":"Lokau","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2025.107658_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jnr.490250402","article-title":"Interleukin-2 enhances chick and rat sympathetic, but not sensory, neurite outgrowth","volume":"25","author":"Haugen","year":"1990","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.phrs.2025.107658_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jnr.490350310","article-title":"Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain","volume":"35","author":"Awatsuji","year":"1993","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.phrs.2025.107658_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1017\/S0317167100032510","article-title":"Growth factors and lymphokines: modulators of cholinergic neuronal activity","volume":"18","author":"Quirion","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib37","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1523\/JNEUROSCI.13-08-03368.1993","article-title":"Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2","volume":"13","author":"Hanisch","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107658_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(96)00460-X","article-title":"Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation","volume":"731","author":"Anisman","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-5728(96)00196-8","article-title":"Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2","volume":"73","author":"Petitto","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(88)90578-1","article-title":"Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus","volume":"462","author":"Bindoni","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(89)91104-9","article-title":"Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system","volume":"498","author":"Araujo","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-8993(00)03317-5","article-title":"Immunohistochemical localization of interleukin-2 and its receptor subunits alpha, beta and gamma in the main olfactory bulb of the rat","volume":"893","author":"Wang","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0306-4522(91)90259-Q","article-title":"Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain","volume":"44","author":"Lapchak","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107658_bib44","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.4049\/jimmunol.136.9.3239","article-title":"Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain","volume":"136","author":"Hofman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0304-3940(93)90013-B","article-title":"Interleukin-2 enhances the viability of primary cultured rat neocortical neurons","volume":"151","author":"Shimojo","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107658_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-8993(94)90216-X","article-title":"Molecular cloning of a partial cDNA of the interleukin-2 receptor-beta in normal mouse brain: in situ localization in the hippocampus and expression by neuroblastoma cells","volume":"650","author":"Petitto","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0169-328X(97)00276-3","article-title":"Molecular cloning of the cDNA coding sequence of IL-2 receptor-gamma (gammac) from human and murine forebrain: expression in the hippocampus in situ and by brain cells in vitro, Brain Res","volume":"53","author":"Petitto","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib48","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1471-4159.1987.tb10020.x","article-title":"Myelin basic protein-specific RNA levels in interleukin-2-stimulated oligodendrocytes","volume":"49","author":"Benveniste","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2025.107658_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/mcne.1994.1027","article-title":"Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines","volume":"5","author":"Zwain","year":"1994","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.phrs.2025.107658_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5728(91)90112-K","article-title":"Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats","volume":"33","author":"Ellison","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-5728(90)90018-I","article-title":"Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions","volume":"28","author":"Ellison","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1523\/JNEUROSCI.14-02-00846.1994","article-title":"Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines","volume":"14","author":"Balasingam","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107658_bib53","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1073\/pnas.89.12.5442","article-title":"Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration","volume":"89","author":"Eitan","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107658_bib54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/endo.132.1.8419142","article-title":"Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6","volume":"132","author":"Arzt","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2025.107658_bib55","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1073\/pnas.90.8.3383","article-title":"Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami","volume":"90","author":"Karanth","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107658_bib56","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1523\/JNEUROSCI.14-10-06187.1994","article-title":"IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling","volume":"14","author":"Raber","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107658_bib57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00001756-199303000-00019","article-title":"Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus","volume":"4","author":"Lapchak","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2025.107658_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0028-3908(90)90057-X","article-title":"Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone","volume":"29","author":"Sarro","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107658_bib59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib61","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awab094","article-title":"Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease","volume":"144","author":"Asby","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107658_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib63","first-page":"847","article-title":"[Polymorphic markers of some genes associated with multiple sclerosis in the population of Kazakhstan]","volume":"47","author":"A\u012dtxozhina","year":"2011","journal-title":"Genetika"},{"key":"10.1016\/j.phrs.2025.107658_bib64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2370.2002.00338.x","article-title":"Analysis of -631 and -475 interleukin-2 promoter single nucleotide polymorphisms in multiple sclerosis","volume":"29","author":"Fedetz","year":"2002","journal-title":"Eur. J. Immunogenet."},{"key":"10.1016\/j.phrs.2025.107658_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/08820139.2018.1425699","article-title":"Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk","volume":"47","author":"Wang","year":"2018","journal-title":"Immunol. Invest"},{"key":"10.1016\/j.phrs.2025.107658_bib66","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1038\/ncomms6056","article-title":"Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells","volume":"5","author":"Hartmann","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107658_bib67","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/cells8060634","article-title":"Relationship between multiple sclerosis-associated IL2RA risk allele variants and circulating t cell phenotypes in healthy genotype-selected controls","volume":"8","author":"Buhelt","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107658_bib68","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/biomedicines8070226","article-title":"Increased IL-2 and Reduced TGF-\u03b2 Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis","volume":"8","author":"Aram","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2025.107658_bib69","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00415-006-0416-4","article-title":"IL2RA\/CD25 polymorphisms contribute to multiple sclerosis susceptibility","volume":"254","author":"Matesanz","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577499","article-title":"NK\/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis","volume":"353","author":"Mimpen","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib71","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.182.3.1541","article-title":"Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses","volume":"182","author":"Maier","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-5728(91)90070-N","article-title":"The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis","volume":"32","author":"Sharief","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jnnp.56.2.169","article-title":"Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis","volume":"56","author":"Sharief","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107658_bib74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/08923973.2017.1369099","article-title":"DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice","volume":"39","author":"Bhopale","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.phrs.2025.107658_bib75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/biomedicines11010178","article-title":"Osteopontin is associated with multiple sclerosis relapses","volume":"11","author":"Bassi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2025.107658_bib76","first-page":"203","article-title":"The nature of inflammatory components during demyelination in multiple sclerosis","volume":"20","author":"Cuzner","year":"1988","journal-title":"Trials"},{"key":"10.1016\/j.phrs.2025.107658_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100123","article-title":"The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis","volume":"4","author":"Peerlings","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.phrs.2025.107658_bib78","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/cells1030576","article-title":"Neuroantigen-specific CD4 cells expressing interferon-\u03b3 (IFN-\u03b3), interleukin (IL)-2 and IL-3 in a mutually exclusive manner prevail in experimental allergic encephalomyelitis (EAE)","volume":"1","author":"Karulin","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107658_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156457","article-title":"Induction of IL-2 by interleukin-12 p40 homodimer and IL-12, but not IL-23, in microglia and macrophages: implications for multiple sclerosis","volume":"174","author":"Jana","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2025.107658_bib80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-5728(94)90010-8","article-title":"Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion","volume":"55","author":"Schroeter","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(93)91058-Z","article-title":"MHC class II antigen expression and T-cell infiltration in the demyelinating CNS and PNS of the twitcher mouse","volume":"625","author":"Ohno","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107658_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.107658_bib83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib84","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-019-0521-4","article-title":"GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis","volume":"25","author":"Galli","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib85","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107658_bib86","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/molecules28083480","article-title":"The SEB1741 aptamer is an efficient tool for blocking CD4+\u2009T cell activation induced by staphylococcal enterotoxin B","volume":"28","author":"Chavez-Galan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.107658_bib87","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","article-title":"An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells","volume":"185","author":"Martin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib88","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107658_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008127.pub4","article-title":"Daclizumab for relapsing remitting multiple sclerosis","author":"Liu","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2025.107658_bib90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archneurol.2009.50","article-title":"Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis","volume":"66","author":"Bielekova","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib91","first-page":"977","article-title":"Therapeutic effect of low dose interleukin-2 on experimental autoimmune encephalo-myelitis in mice","volume":"972","author":"Zhen","year":"2017","journal-title":"Mil. Med. 968-"},{"key":"10.1016\/j.phrs.2025.107658_bib92","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archneurol.2009.16","article-title":"Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis","volume":"66","author":"Oh","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib93","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/imt-2021-0045","article-title":"Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosis","volume":"14","author":"Ghorbani","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.phrs.2025.107658_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.107658_bib95","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbadis.2015.10.015","article-title":"Myeloid derived suppressor cells in inflammatory conditions of the central nervous system","volume":"1862","author":"Melero-Jerez","year":"2016","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2025.107658_bib96","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib97","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/protein\/1.6.493","article-title":"Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein","volume":"1","author":"Williams","year":"1987","journal-title":"Protein Eng."},{"key":"10.1016\/j.phrs.2025.107658_bib98","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2025.107658_bib99","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10072-010-0221-9","article-title":"Cytokine polymorphisms and Alzheimer disease: possible associations","volume":"31","author":"Ribizzi","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2022.05.006","article-title":"Causal effects of circulating cytokine concentrations on risk of Alzheimer's disease and cognitive function","volume":"104","author":"Pagoni","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2025.107658_bib101","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","article-title":"Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias","volume":"89","author":"King","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107658_bib102","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3390\/biomedicines11092394","article-title":"Concordant and discordant cerebrospinal fluid and plasma cytokine and chemokine responses in mild cognitive impairment and early-stage Alzheimer's disease","volume":"11","author":"Monte","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2025.107658_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13195-023-01323-5","article-title":"Long-term normalization of calcineurin activity in model mice rescues Pin1 and attenuates Alzheimer's phenotypes without blocking peripheral T cell IL-2 response","volume":"15","author":"Stallings","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.phrs.2025.107658_bib104","first-page":"5015","article-title":"Anti-inflammatory effects of bone marrow mesenchymal stem cells on mice with Alzheimer's disease","volume":"16","author":"Wei","year":"2018","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib105","first-page":"421","article-title":"Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer's disease-like pathologies in APP\/PS1 mouse model","volume":"12","author":"Yang","year":"2020","journal-title":"Chin. Herb. Med"},{"key":"10.1016\/j.phrs.2025.107658_bib106","doi-asserted-by":"crossref","unstructured":"D.M. Araujo, P.A.L.J. Neuroscience, Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors, 61(1994) 745-754, https:\/\/doi.org\/10.1016\/0306-4522(94)90398-0.","DOI":"10.1016\/0306-4522(94)90398-0"},{"key":"10.1016\/j.phrs.2025.107658_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066664","article-title":"Enhanced chemokine receptor expression on leukocytes of patients with Alzheimer's disease","volume":"8","author":"Goldeck","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107658_bib108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0895-3988(10)60072-4","article-title":"An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: a systematic review","volume":"23","author":"Wang","year":"2010","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib109","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.1002\/jcp.26843","article-title":"Effect of microRNA-186 on oxidative stress injury of neuron by targeting interleukin 2 through the janus kinase-signal transducer and activator of transcription pathway in a rat model of Alzheimer's disease","volume":"233","author":"Wu","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2025.107658_bib110","first-page":"113","article-title":"Effects of acupuncture stimulation of bilateral \"hegu\" (LI 4) and \"Taichong\" (LR 3) on learning-memory ability, hippocampal AP 42 expression and inflammatory cytokines in rats with Alzheimer's disease]","volume":"41","author":"Jiang","year":"2016","journal-title":"Zhen Ci Yan Jiu"},{"key":"10.1016\/j.phrs.2025.107658_bib111","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awv408","article-title":"Regulatory T cells delay disease progression in Alzheimer-like pathology","volume":"139","author":"Dansokho","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107658_bib112","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11481-023-10090-x","article-title":"Low-dose IL-2 treatment rescues cognitive deficits by repairing the imbalance between treg and Th17 cells at the middle Alzheimer's disease stage","volume":"18","author":"Yuan","year":"2023","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.phrs.2025.107658_bib113","doi-asserted-by":"crossref","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+Foxp3+\u2009regulatory T cells in a 3xTg-AD Alzheimer's disease model","volume":"7","author":"Baek","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107658_bib114","first-page":"826","article-title":"Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice","volume":"140","author":"Alves","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107658_bib115","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107658_bib116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107658_bib117","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/bc.bc_40_23","article-title":"Identification of brain endothelial cell-specific genes and pathways in ischemic stroke by integrated bioinformatical analysis","volume":"9","author":"Yan","year":"2023","journal-title":"Brain Circ."},{"key":"10.1016\/j.phrs.2025.107658_bib118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/156720207779940716","article-title":"TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents","volume":"4","author":"Al-Bahrani","year":"2007","journal-title":"Curr. Neurovasc Res"},{"key":"10.1016\/j.phrs.2025.107658_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008718","article-title":"Functional status of peripheral blood T-cells in ischemic stroke patients","volume":"5","author":"Vogelgesang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107658_bib120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.118.035905","article-title":"Genetically determined levels of circulating cytokines and risk of stroke","volume":"139","author":"Georgakis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2025.107658_bib121","article-title":"Inflammatory cytokines and risk of ischemic stroke: a mendelian randomization study","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107658_bib122","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2006.05.098","article-title":"Transient ischemia-induced changes of interleukin-2 and its receptor beta immunoreactivity and levels in the gerbil hippocampal CA1 region","volume":"1106","author":"Hwang","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2025.107658_bib123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(97)00154-8","article-title":"Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion","volume":"152","author":"Zhai","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation Through Reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/jcbfm.2012.128","article-title":"Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO","volume":"33","author":"Stubbe","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2025.107658_bib126","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00011-009-0036-4","article-title":"Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10","volume":"58","author":"Nayak","year":"2009","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.phrs.2025.107658_bib127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12974-020-01920-3","article-title":"Prognostic significance of plasma IL-2 and sIL-2R\u03b1 in patients with first-ever ischaemic stroke","volume":"17","author":"Zhao","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.107658_bib128","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1177\/0271678X221106956","article-title":"Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke","volume":"42","author":"Scott","year":"2022","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2025.107658_bib129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2012.04.025","article-title":"Comparison of inflammatory cytokines changes in the hippocampal CA1 region between the young and adult gerbil after transient cerebral ischemia","volume":"1461","author":"Yan","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2025.107658_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25276","article-title":"Selective vulnerability of hippocampal CA1 and CA3 pyramidal cells: What are possible pathomechanisms and should more attention be paid to the CA3 region in future studies?","volume":"102","author":"Einenkel","year":"2024","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.phrs.2025.107658_bib131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107658_bib132","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","article-title":"Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke","volume":"54","author":"Shi","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.107658_bib133","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1523\/JNEUROSCI.3411-17.2018","article-title":"In vivo expansion of regulatory T cells with IL-2\/IL-2 antibody complex protects against transient ischemic stroke","volume":"38","author":"Zhang","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107658_bib134","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12017-021-08656-0","article-title":"IL-2\/IL-2R antibody complex enhances treg-induced neuroprotection by dampening TNF-\u03b1 inflammation in an in vitro stroke model","volume":"23","author":"Borlongan","year":"2021","journal-title":"Neuromolecul Med"},{"key":"10.1016\/j.phrs.2025.107658_bib135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pneurobio.2016.04.005","article-title":"White matter injury in ischemic stroke","volume":"141","author":"Wang","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107658_bib136","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cns.13084","article-title":"IL-2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8+\u2009T cells","volume":"25","author":"Zhou","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2025.107658_bib137","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12026-013-8452-5","article-title":"The IL-2\/IL-2R system: from basic science to therapeutic applications to enhance immune regulation","volume":"57","author":"Bayer","year":"2013","journal-title":"Immunol. Res"},{"key":"10.1016\/j.phrs.2025.107658_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101435","article-title":"Memory CD8+\u2009T cell responses to cancer","volume":"49","author":"Han","year":"2020","journal-title":"Semin Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib139","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining Memory CD8 T Cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib140","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2147\/NDT.S274487","article-title":"Comparisons between infectious and autoimmune encephalitis: clinical signs, biochemistry, blood counts, and imaging findings","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2025.107658_bib141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/bc.bc_97_22","article-title":"Localization of cerebral vasculopathy following bacterial meningitis: what can we learn about postinfective ischemic sequelae?","volume":"9","author":"Kumar","year":"2023","journal-title":"Brain Circ."},{"key":"10.1016\/j.phrs.2025.107658_bib142","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/341301","article-title":"Burden of encephalitis-associated hospitalizations in the United States, 1988-1997","volume":"35","author":"Khetsuriani","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phrs.2025.107658_bib143","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.phrs.2025.107658_bib144","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/dna.2013.1997","article-title":"Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis","volume":"32","author":"Piskin","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.phrs.2025.107658_bib146","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3389\/fimmu.2019.02066","article-title":"Innate immunity in the central nervous system: a missing piece of the autoimmune encephalitis puzzle?","volume":"10","author":"Wesselingh","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107658_bib147","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582296","article-title":"Cytokines\/chemokines: potential biomarkers for non-paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2025.107658_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136170","article-title":"Cytokines and chemokines expression pattern in herpes simplex virus type-1 encephalitis","volume":"763","author":"Wang","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107658_bib150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02829559","article-title":"Expression of cytokines IL-2, IL-10 and TNF-alpha in mice with herpes simplex viral encephalitis","volume":"26","author":"Wei","year":"2006","journal-title":"J. Huazhong Univ. Sci. Technol. Med Sci."},{"key":"10.1016\/j.phrs.2025.107658_bib151","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.braindev.2009.04.018","article-title":"Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis","volume":"32","author":"Aydin","year":"2010","journal-title":"Brain Dev."},{"key":"10.1016\/j.phrs.2025.107658_bib152","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/515195","article-title":"Tick-borne encephalitis","volume":"28","author":"Dumpis","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phrs.2025.107658_bib153","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107658_bib154","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virusres.2005.04.007","article-title":"Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis","volume":"111","author":"Mandl","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.phrs.2025.107658_bib155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2009.04.026","article-title":"Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses","volume":"390","author":"Hayasaka","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.phrs.2025.107658_bib156","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0300985810372507","article-title":"Flavivirus encephalitis: pathological aspects of mouse and other animal models","volume":"47","author":"Kimura","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.phrs.2025.107658_bib157","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1038\/srep05344","article-title":"Protective role of TNF-\u03b1, IL-10 and IL-2 in mice infected with the Oshima strain of Tick-borne encephalitis virus","volume":"4","author":"Tun","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107658_bib158","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2016.09.001","article-title":"New feasible treatment for refractory autoimmune encephalitis: low-dose interleukin-2","volume":"299","author":"Lim","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2025.107658_bib159","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.4049\/jimmunol.135.6.4160","article-title":"In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii","volume":"135","author":"Sharma","year":"1985","journal-title":"J. Immunol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:44:20Z","timestamp":1778795060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":159,"alternative-id":["S1043661825000830"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107658","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-2 and its receptors: Implications and therapeutic prospects in immune-mediated disorders of central nervous system","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107658"}}